BioNTech SE ADR (BNTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

AN DER GOLDGRUBE 12 MAINZ, GERMANY 55131

BioNTech SE provides biotechnological solutions. The Company develops various types of treatments for cancer patient's tumor. BioNTech serves customers worldwide.

Data as of 2021-01-16
Market Cap24.461 Billion Shares Outstanding240.786 Million Avg 30-day Volume4.067 Million
P/E Ratio-49.7 Dividend Yield EPS-1.04
Price/Sales152.424 Price cash flow ratio Price free cash flow ratio-69.7
Book Value4.69 Price to Tangible Book23.13 Alpha0.19
Short Interest Ratio % Short Interest to Float R-squared0.158218
BETA-1.75183 52-week High/Low131.0 / 28.0 Stddev0.304357
View SEC Filings from BNTX instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 3 -66.67% 0 (0.0%) 2 (0.13%) -100.0%
Funds Holding: 142 107 32.71% 37 (2.43%) 31 (2.01%) 19.35%
13F shares: 24.251 Million 26.61 Million -8.87% 6.396 Million 8.047 Million -20.52%
% Ownership 10.1819 11.1726 -8.87% 2.6853 3.3786 -20.52%
New Positions: 56 76 -26.32% 14 25 -44.0%
Increased Positions 48 19 152.63% 13 3 333.33%
Closed Positions 18 6 200.0% 8 2 300.0%
Reduced Positions 25 7 257.14% 8 2 300.0%
Total Calls 1.462 Million 518.18 Thousand 182.11% 421.7 Thousand 141.3 Thousand 198.44%
Total Puts 2.824 Million 405.002 Thousand 597.21% 643.8 Thousand 12.3 Thousand 5134.15%
PUT/CALL Ratio 1.93 0.78 147.44% 1.53 0.09 1600.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding BNTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BNTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments